190 related articles for article (PubMed ID: 21801376)
1. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria.
Reinhard H; Nybo M; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rasmussen LM; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2011 Jul; 10():70. PubMed ID: 21801376
[TBL] [Abstract][Full Text] [Related]
2. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate.
Reinhard H; Hansen PR; Persson F; Tarnow L; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Nephrol Dial Transplant; 2011 Oct; 26(10):3242-9. PubMed ID: 21372253
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
[TBL] [Abstract][Full Text] [Related]
4. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate.
Joergensen C; Reinhard H; Schmedes A; Hansen PR; Wiinberg N; Petersen CL; Winther K; Parving HH; Jacobsen PK; Rossing P
Diabetes Care; 2012 Jan; 35(1):168-72. PubMed ID: 22040839
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
Ahmed S; Sobh R
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
[TBL] [Abstract][Full Text] [Related]
9. Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk.
Davenport C; Ashley DT; O'Sullivan EP; Corley BT; Fitzgerald P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
J Hypertens; 2011 Dec; 29(12):2469-75. PubMed ID: 21970938
[TBL] [Abstract][Full Text] [Related]
10. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
[TBL] [Abstract][Full Text] [Related]
11. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
Hosbond SE; Diederichsen AC; Saaby L; Rasmussen LM; Lambrechtsen J; Munkholm H; Sand NP; Gerke O; Poulsen TS; Mickley H
Atherosclerosis; 2014 Oct; 236(2):230-6. PubMed ID: 25104079
[TBL] [Abstract][Full Text] [Related]
12. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.
Ghaffari S; Yaghoubi A; Baghernejad R; Sepehrvand N; Sokhanvar S; Haghjou AG
Cardiol J; 2013; 20(3):261-7. PubMed ID: 23788300
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery calcium score and N-terminal pro-B-type natriuretic peptide as potential gatekeepers for myocardial perfusion imaging.
Haarmark C; Andersen KF; Madsen C; Zerahn B
Clin Physiol Funct Imaging; 2017 Nov; 37(6):710-716. PubMed ID: 27005324
[TBL] [Abstract][Full Text] [Related]
14. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.
Avignon A; Sultan A; Piot C; Elaerts S; Cristol JP; Dupuy AM
Diabetes Care; 2005 Sep; 28(9):2176-80. PubMed ID: 16123486
[TBL] [Abstract][Full Text] [Related]
17. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
18. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
Jian W; Mo CH; Yang GL; Li L; Gui C
J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin and mortality in type 2 diabetic patients.
Reinhard H; Lajer M; Gall MA; Tarnow L; Parving HH; Rasmussen LM; Rossing P
Diabetes Care; 2010 Dec; 33(12):2561-6. PubMed ID: 20929997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
